RDNT vs UHS

For growth investors, RadNet, Inc.

(RDNT) is the stronger pick with 11. 5% revenue growth year-over-year, versus 9. 7% for Universal Health Services, Inc. (UHS). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 4x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Universal Health Services, Inc.

is actually cheaper at 7. 3x.

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to +12. 5% for Universal Health Services, Inc. (UHS). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus UHS's +30. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Universal Health Services, Inc.

(UHS) is the lower-risk stock at 0. 60β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 136% more volatile than UHS relative to the S&P 500. On balance sheet safety, Universal Health Services, Inc. (UHS) carries a lower debt/equity ratio of 74% versus 137% for RadNet, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), RadNet, Inc.

(RDNT) is pulling ahead at 11. 5% versus 9. 7% for Universal Health Services, Inc. (UHS). On earnings-per-share growth, the picture is similar: Universal Health Services, Inc. grew EPS 37. 3% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Universal Health Services, Inc.

(UHS) is the more profitable company, earning 8. 6% net margin versus 2. 3% for RadNet, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UHS leads at 11. 5% versus 3. 0% for RDNT. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Universal Health Services, Inc.

(UHS) trades at 7. 3x forward P/E versus 91. 8x for RadNet, Inc. — 84. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RDNT: 60. 0% to $92. 00.

In this comparison, UHS (0.

5% yield) pays a dividend. RDNT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Universal Health Services, Inc.

(UHS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60)). Both have compounded well over 10 years (UHS: +30. 8%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RDNT is a small-cap quality compounder stock; UHS is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.